According to experts, the new blood thinner Pradaxa has been linked to an increased risk of serious life-threatening bleeding. Now many experts are questioning its safety. PRADAXA LAWSUIT STATUS Users of Pradaxa who suffered severe internal bleeding, hemorrhages or other problems may be eligible to pursue a Pradaxa lawsuit. Our…
SSRIs are a widely prescribed class of drugs most often used as antidepressants to treat depression and anxiety disorders. Since September 2005, scientific information has been emerging that certain SSRIs, such as Celexa (citalopram), Lexapro (escitalopram), Prozac (fluoxetine), and Zoloft (sertraline), and SNRI antidepressants, such as Effexor (venlafaxine) may cause…
Following the lead of the Federal Court ordered mediation in the Yaz/Yasmin litigation, the Pennsylvania state court judge has entered a similar order. Judge Moss, who is managing thousands of cases in Philadelphia state court, required mediation in an order published on January 6, 2012. Judge Moss’s order comes just…
Medical side effect concerns about Tekturna, a blood pressure drug sold by Novartis, have arisen after clinical trials were canceled due to a high number of strokes and kidney problems among diabetic patients. Novartis was running a trial of the drug to see if it could be useful in the…
The federal judge overseeing the thousands of Yaz, Yasmin and Ocella venous thrombo-embolism lawsuits, has delayed the first trial scheduled to begin January 9th. The Court ordered the parties to meet with a special mediator in an attempt to negotiate a settlement for the litigation. The first Yaz trial was…
The Judicial Panel on Multidistrict Litigation (JPML) is streamlining litigation for all federal cases alleging injury caused by the diabetes drug ACTOS®. These cases will now be brought under MDL No. 2299. On the basis of the papers filed and the hearing session held, the JPML found that eleven current…
The human tragedy of the most widespread medical implant failure in decades continues to unfold. These involve thousands of all-metal artificial hips that need to be replaced. And now as the litigation slowly grinds on, it has entered its most important phase of cost, both in financial terms and the…
Three Fosamax jaw decay lawsuits are scheduled to go to trial in 2012, including a new trial on damages in one case that resulted in an $8 million jury award in 2010. U.S. District Judge John Keenan issued an order calling for additional Fosamax bellwether trials to take place in…
The FDA is concerned over new liquid acetaminophen products for infants because of the possibility of accidental Tylenol overdoses and dosing confusion by parents. The FDA issued a consumer update on December 22, warning parents that several new liquid acetaminophen products for infants have different potency than older liquid acetaminophen…
A recent Australian study indicates that the newer technology for artificial hips and knees did not perform any better than older, well tested and less expensive designs. This week, data was published from Australia’s orthopedic registry, which covered implants introduced from 2003 to 2007. The study’s findings are significant for…